Neuropsychologists and Pharmacy Lien Programs: TBI Case Coordination Guide

James Wong — Founder & Pharmacist, LienScripts | November 21, 2025 | 9 min read

Neuropsychologists play a critical role in TBI personal injury litigation. The medications prescribed alongside neuropsychological treatment — cognitive aids, antidepressants, sleep medications, stimulants — are all coverable under pharmacy lien programs and provide powerful case documentation.

Neuropsychology's Role in TBI PI Litigation

Traumatic brain injury (TBI) cases are among the most complex and highest-value personal injury matters. Neuropsychologists occupy a specialized and essential role in these cases — as treating clinicians, as expert witnesses at trial, and as the authors of neuropsychological evaluations that document cognitive, emotional, and behavioral impairments.

In personal injury practice, a neuropsychologist may be engaged:

1. As a treating provider — conducting cognitive rehabilitation, psychotherapy for emotional TBI sequelae, and functional assessment
2. As a retained expert — administering neuropsychological testing (MMSE, MoCA, Trails B, WAIS-IV, memory testing) and providing expert opinion on cognitive deficits and causation
3. As a coordinating clinician — working with the treating neurologist and psychiatrist to manage the patient's overall TBI recovery

When a neuropsychologist is involved in a TBI PI case, a characteristic medication regimen typically accompanies their work — prescriptions ordered by the treating neurologist or psychiatrist based on the neuropsychologist's assessment findings. These medications are coverable under pharmacy lien programs.

[!KEY] The medications prescribed in conjunction with neuropsychological treatment for TBI are not incidental — they are medically necessary pharmaceutical supports for documented cognitive, emotional, and sleep deficits. Their presence in the pharmacy record corroborates the neuropsychological findings and adds economic damages documentation to the PI demand.

Medications Used Alongside Neuropsychological Treatment

Cognitive stimulants and wake-promoting agents:

Modafinil (Provigil) / Armodafinil (Nuvigil): TBI patients frequently experience excessive daytime sleepiness, fatigue, and cognitive "brain fog" — conditions that respond to wake-promoting agents. Modafinil is prescribed off-label for TBI-related cognitive fatigue, with significant clinical evidence supporting its use. It is a Schedule IV controlled substance.

Methylphenidate (Ritalin) / Amphetamine salts (Adderall): Stimulants are sometimes prescribed for TBI-related attention and processing speed deficits that resemble acquired ADHD. These are Schedule II controlled substances and require careful prescriber documentation.

Amantadine: Originally an antiviral, amantadine has evidence for improving arousal, attention, and cognitive function in moderate-to-severe TBI during the recovery phase.

Antidepressants for TBI emotional sequelae:

Sertraline, escitalopram, bupropion: Depression is one of the most common emotional sequelae of TBI. SSRIs and SNRIs are first-line for post-TBI depression and also have cognitive benefits in some patients.

Duloxetine: SNRI with both antidepressant and pain benefits — useful when TBI is accompanied by chronic pain.

Mood stabilizers for TBI irritability/agitation:

Valproate, lamotrigine: Used for irritability, emotional dysregulation, and behavioral changes after TBI.

Sleep medications for TBI sleep-wake dysfunction:

Melatonin (prescription-strength), zolpidem, trazodone: TBI disrupts circadian rhythm and sleep architecture at a neurobiological level. Pharmacological sleep support is often necessary.

Neuropathic pain agents:

Gabapentin, pregabalin: For TBI patients with concurrent peripheral nerve injury or central sensitization.

The Neuropsychological Evaluation and Pharmacy Records: Mutual Corroboration

A neuropsychological evaluation that documents memory deficits, processing speed impairment, attention difficulties, and emotional dysregulation is more powerful when corroborated by a concurrent pharmacy record showing pharmaceutical management of those same deficits.

Defense challenge: "The neuropsychological testing results reflect effort problems, not genuine impairment."

Response: The pharmacy record shows that the treating physician — not a retained expert — was prescribing cognitive stimulants and antidepressants for TBI-related complaints. This is corroborating evidence of genuine impairment from the treating clinician.

Defense challenge: "The client's cognitive complaints are pre-existing."

Response: The pharmacy record documents that these medications were first prescribed after the accident date — establishing the temporal relationship between the injury and the pharmacological treatment.

[!NOTE] In TBI cases, request pharmacy records from before the accident as well as after. If stimulants, cognitive aids, or antidepressants were not prescribed before the accident but appear in the record after, the temporal pattern is powerful causation evidence.

How Neuropsychological Testing Supports the Medication Claim

When a neuropsychologist administers testing and documents deficits in specific cognitive domains, it creates the clinical foundation for the medications prescribed:

When the neuropsychological report and the pharmacy record tell the same story — documented deficits matched by medications targeting those specific deficits — the medical necessity of each prescription is nearly unassailable.

[!KEY] A neuropsychological evaluation that documents cognitive deficits, paired with a pharmacy record showing stimulants or cognitive aids first prescribed after the accident date, creates a causal chain — evaluation identifies the deficit, prescriber responds with targeted medication, pharmacy fills it — that is far harder to rebut than neuropsychological testing results alone.

Working with Neuropsychologists on PI Cases

For PI attorneys managing TBI cases, neuropsychologist coordination involves:

[!KEY] Request the neuropsychological evaluation early in the case, before a defense IME can establish a competing baseline — the neuropsychologist's findings directly shape the medication regimen, and the pharmacy record should begin tracking those prescriptions from the first neuropsychological appointment.

Early evaluation: Request a neuropsychological evaluation early in the case — ideally before a defense IME can establish a competing baseline. The neuropsychologist's findings shape the treatment plan and the associated pharmacy record.

Medication tracking: Ensure the client is enrolled in a pharmacy lien program so that every prescription arising from the TBI treatment — stimulants, antidepressants, sleep medications — is captured in the pharmacy record from day one.

MERIT at settlement: The MERIT report from LienScripts itemizes every TBI-related medication with pharmacist attestation. In a catastrophic TBI case, this may represent 12–36 months of medication fills across multiple drug categories — a substantial economic damages exhibit.

Expert coordination: If the neuropsychologist will testify as an expert, ensure that their opinion addresses the pharmaceutical treatment plan. A neuropsychologist who can explain why the medications were prescribed, and how they address the specific deficits documented in testing, makes the pharmacy record more defensible.

[!TIP] For TBI cases with cognitive stimulant prescriptions (modafinil, methylphenidate), prepare a defense response to "addiction/abuse" challenges. These medications are prescribed by physicians for documented neurological deficits — the prescribing context is entirely different from recreational use.

Pharmacy Lien Coverage for TBI Medications

All medications prescribed by the treating neurologist or psychiatrist as part of the TBI management plan are coverable under pharmacy lien programs, including:

• Schedule II stimulants (methylphenidate, amphetamine) with proper prescriber documentation
• Schedule IV wake-promoting agents (modafinil, zolpidem)
• Non-scheduled medications (amantadine, SSRIs, mood stabilizers, antidepressants)

LienScripts handles Schedule II and IV controlled substances under full DEA compliance, with proper prescription verification at each fill.

Related Resources

• Traumatic Brain Injury Lien-Based Care
• Concussion and TBI Medication Guide
• Pharmacy Lien Support for Neurology
• Complete Lien-Based Care Team for Personal Injury
• Pharmacy Services for Personal Injury Clients

[!SOURCE] Zollman FS (Ed.), Manual of Traumatic Brain Injury, 2nd ed. — Comprehensive clinical reference for TBI management including pharmacological treatment of cognitive, emotional, and sleep sequelae.

[!SOURCE] Giacino JT et al., "Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury," NEJM, 2012 — Randomized trial demonstrating amantadine's role in improving outcomes in TBI patients, supporting its use in PI medication regimens.